Antigen Express

Companies Antigen Express

News Antigen Express

• Generex Oncology Names Dr. Craig Eagle to its Scientific Advisory Board to Assist with its Proprietary Cancer Vaccines Program

  Generex Biotechnology Corporation announced that it has named Craig Eagle, M.D. to its scientific advisory board. Dr. Eagle brings a wealth of oncology experience to help the Company’s wholly-owned subsidiary, Antigen Express, Inc., dba “Generex Oncology”, further its synthetic cancer and influenza more

• Generex Oncology Granted United States Patent for AE37 Peptide Vaccine

  Generex Biotechnology Corporation announced that its wholly-owned subsidiary, Antigen Express, Inc., has been granted a United States patent on AE37, its lead immunotherapeutic vaccine. While Antigen Express has a strong intellectual property foundation on all Ii-Key technology, this is the first “ more

• Generex Subsidiary Antigen Express Receives Patent in China for Its Ii-Key Peptide Vaccine Technology

  Generex Biotechnology Corporation announced that it has received notice of issuance of a patent on its Ii-Key peptide technology in China. This expands a solid intellectual property estate that includes both broad claims covering its technology as well as specific Ii-Key-containing drug development more

Publications Antigen Express

• Recruitment of EB1, a Master Regulator of Microtubule Dynamics, to the Surface of the Theileria annulata Schizont

  by Kerry L. Woods, Romina Theiler, Marcus Mühlemann, Adrian Segiser, Sandra Huber, Hifzur R. Ansari, Arnab Pain, Dirk A. E. Dobbelaere The apicomplexan parasite Theileria annulata transforms infected host cells, inducing uncontrolled proliferation and clonal expansion of the parasitized cell popul more

• Targeting T cells to tumor cells using bispecific antibodies

  Publication date: Available online 25 April 2013Source:Current Opinion in Chemical Biology Author(s): Stanley R Frankel , Patrick A Baeuerle The immune system, and in particular T cells, can be harnessed to treat cancer. Several bispecific T cell engaging antibodies of the BiTE® format are in more

• Peripheral CD4+ T‐cell tolerance is induced in vivo by rare antigen‐bearing B cells in follicular, marginal zone, and B‐1 subsets

  B cells are efficient APCs when they internalize antigen via BCR‐mediated uptake. Adoptively transferred antigen‐presenting B cells can induce T‐cell tolerance to foreign and self antigens; however, it is unknown whether endogenous B cells presenting self‐peptides interact with naïve T cells and c more

Websites Antigen Express